Results 191 to 200 of about 22,643,381 (355)
Maximum Likelihood Estimation of the Multivariate Normal Mixture Model [PDF]
The Hessian of the multivariate normal mixture model is derived, and estimators of the information matrix are obtained, thus enabling consistent estimation of all parameters and their precisions.
Boldea, Otilia, Magnus, Jan R.
core +1 more source
Isolation and Properties of the Abnormal Factor IX Molecule of Hemophilia BM [PDF]
Bjarne Østerud+3 more
openalex +1 more source
ABSTRACT Background Haemophilia is a chronic, lifelong bleeding disorder that requires interdisciplinary care to manage and mitigate the disease burden throughout a patient's life. There is no universally accepted protocol for managing haemophilia patients during dental care.
Mathangi Kumar+6 more
wiley +1 more source
ABSTRACT Introduction Acquired haemophilia A (AHA) is a rare autoimmune disorder caused by autoantibodies against coagulation factor VIII (FVIII), resulting in significant bleeding risks. Aim To characterize the anti‐FVIII antibody profile in AHA patients by assessing isotypes, subclasses, and correlations with key clinical parameters.
Ann‐Cristin Berkemeier+6 more
wiley +1 more source
Collected Experience of the Pennsylvania Hemophilia Program [PDF]
S.S. Shapiro, M.E. Eyster, J. Lewis
openalex +1 more source
A Global Cross‐Sectional Database Study of Low Dose FVIII SHL Prophylaxis in Haemophilia A
ABSTRACT Introduction Haemophilia treatment is costly and only 25% of patients receive adequate care. Although not optimal, Factor VIII (FVIII) low‐dose prophylaxis (LDP) may reduce annual joint bleeding rates. Understanding FVIII usage, collected through the Web‐Accessible Population Pharmacokinetic Service–Hemophilia (WAPPS‐Hemo) platform, and its ...
Dagmar M. Hajducek+4 more
wiley +1 more source
Defibrination Syndrome Developed after Replacement Therapy with PPSB in a Case of Hemophilia B. [PDF]
Mutsuyoshi Kazama+4 more
openalex +1 more source
ABSTRACT Introduction In haemophilia, ever more effective treatment options leading to minimal bleeding make information provision about the disease and its symptoms and when to alert the treatment team increasingly important. However, little is known about how current information provision is perceived and what the needs are.
Caroline M. A. Mussert+12 more
wiley +1 more source
AAV5–Factor VIII Gene Transfer in Severe Hemophilia A
S. Rangarajan+10 more
semanticscholar +1 more source
Burden of Haemophilia A in South Korea: A Serial Cross‐Sectional Study From 2008 to 2021
Abstract Background Overall use of factor VIII (FVIII) and prophylactic use have increased in South Korea over the past decade. However, there are no nationwide outcome data demonstrating its impact. This study aimed to identify patients with haemophilia A (PwHA) and observe trends in joint‐related outcomes and life‐threatening haemorrhages using ...
Sun‐Hong Kwon+7 more
wiley +1 more source